Colin Davis

CRS:

Whitman-Walker

Role:

Research Staff

Position:

Study Coordinator

Colin Davis joined the Whitman-Walker research team as the REPRIEVE study coordinator in July 2016, though he has volunteered with the Gay Men’s Health & Wellness Clinic since 2014. After studying biology and English at William & Mary, Colin fostered an interest in HIV, community health, and LGBT-care through GWU’s graduate certificate program in LGBT Health, an interest he is thrilled to realize through his work with Whitman-Walker. 

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5207, Maintaining Options for Mothers Study (MOMS): A Phase...

A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...

Read More

P2010: Phase III Study of the Virologic Efficacy and Safety...

IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...

Read More

A5279, Phase III Clinical Trial of Ultra-Short-Course...

This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...

Read More

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

A5128: Consent for Use of Stored Patient Specimens for...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...

Read More